|
|
Volumn 4, Issue 11, 2014, Pages 1249-
|
|
PD-1 inhibitor approved for melanoma
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE INHIBITOR;
IPILIMUMAB;
NIVOLUMAB;
PEMBROLIZUMAB;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
PDCD1 PROTEIN, HUMAN;
PROGRAMMED DEATH 1 RECEPTOR;
ARTICLE;
HEAD AND NECK SQUAMOUS CELL CARCINOMA;
HUMAN;
MELANOMA;
MUTATION;
NON SMALL CELL LUNG CANCER;
UNSPECIFIED SIDE EFFECT;
ANTAGONISTS AND INHIBITORS;
DRUG APPROVAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
DRUG APPROVAL;
HUMANS;
MELANOMA;
PROGRAMMED CELL DEATH 1 RECEPTOR;
|
|
EID: 84908432369
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2014-144 Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|